Important from the latest filing.
o Counterfeit Medication Solution: Development is complete, production units
have been available for distribution since September 2004.
o Impaired Clinician: Development is complete, and production units have been
available for distribution since September 2004.
o Patient Safety Solution and Regulatory Compliance Solution: Development is
ongoing. We have produced a standalone prototype, but have yet to complete a
production prototype for a unit integrated directly into the pump that combines
the medications into a solution and then releases them into the intravenous
drip.
o PS(3): Development of a first generation prototype is complete. Final release
of the product is pending refinement (in coordination with the appropriate
government agency), manufacturer-ready engineering, and software modification.
o MS(3): Development is ongoing; assuming adequate funding, we anticipate a
production prototype within twelve months We have not completed software
development or a first generation prototype.
o AS(3): Development is ongoing; assuming adequate funding, we have not
completed software development or a first generation prototype; we anticipate a
prototype within twelve months.
o FS(3): Development is ongoing; assuming adequate funding, we have not
completed software development a first generation prototype; we anticipate a
prototype within twelve months.
o Distilled Spirits Counterfeit Detection Unit: Development is complete for a
first generation prototype. Further development awaits funding.
- - - - -
